Johannes-peter P. Stasch
Wuppertal, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 66 publications
The Concise Guide to PHARMACOLOGY 2025/26: Enzymes.
Journal: British journal of pharmacology
Published: December 29, 2025
The Concise Guide to PHARMACOLOGY 2025/26: Catalytic receptors.
Journal: British journal of pharmacology
Published: December 29, 2025
The Concise Guide to PHARMACOLOGY 2023/24: Enzymes.
Journal: British journal of pharmacology
Published: December 20, 2023
The Concise Guide to PHARMACOLOGY 2023/24: Catalytic receptors.
Journal: British journal of pharmacology
Published: December 20, 2023
The nitric oxide-soluble guanylate cyclase-cGMP pathway in pulmonary hypertension: from PDE5 to soluble guanylate cyclase.
Journal: European respiratory review : an official journal of the European Respiratory Society
Published: September 07, 2023
New Generation of sGC Stimulators: Discovery of Imidazo[1,2-a]pyridine Carboxamide BAY 1165747 (BAY-747), a Long-Acting Soluble Guanylate Cyclase Stimulator for the Treatment of Resistant Hypertension.
Journal: Journal of medicinal chemistry
Published: April 11, 2023
Identification and characterization of the new generation soluble guanylate cyclase stimulator BAY-747 designed for the treatment of resistant hypertension.
Journal: British journal of pharmacology
Published: August 10, 2022
Inhaled mosliciguat (BAY 1237592): targeting pulmonary vasculature via activating apo-sGC.
Journal: Respiratory research
Published: May 06, 2022
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Enzymes.
Journal: British journal of pharmacology
Published: September 16, 2021
Soluble GC stimulators and activators: Past, present and future.
Journal: British journal of pharmacology
Published: August 23, 2021
Runcaciguat, a novel soluble guanylate cyclase activator, shows renoprotection in hypertensive, diabetic, and metabolic preclinical models of chronic kidney disease.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: August 09, 2021
Discovery of the Soluble Guanylate Cyclase Activator Runcaciguat (BAY 1101042).
Journal: Journal of medicinal chemistry
Published: April 19, 2021
Last Updated: 09/26/2026